On May 16, 2025, Ekso Bionics Holdings, Inc. held its Annual Meeting where stockholders approved a reverse stock split in a ratio of 1-for-15, aimed at maintaining its Nasdaq listing after previously failing to meet bid price requirements. The changes also include electing board members and increasing the equity incentive plan shares from 4.7 million to 7 million.